APOE4 increases the risk of metabolic syndrome [36] and diseases characterized by peripheral metabolic dysfunction such as obesity and type 2 diabetes, are also risk factors for AD [37]. Here, APOE is linked to obesity due to melanocortin 4 receptor deficiency.